CytomX Therapeutics, Inc. (CTMX) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-06-22

CytomX Therapeutics, Inc. (CTMX) has filed 8 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-22. 3 Form 8-K material event filings were reported by CTMX in the last 90 days. InsiderAlpha tracks every CTMX SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About CytomX Therapeutics, Inc. (CTMX)

SEC CIK0001501989

90-Day SEC Filing Activity

Form 4 filings (90d)8
Form 8-K filings (90d)3
Latest Form 4 filing2026-06-22

Recent CTMX Insider Transactions (Form 4)

DateInsiderRoleTransactionSharesPriceValueFiling
Ogden ChristopherChief Financial OfficerS — Open-market sale1.6K$3.05$5KSEC
Ogden ChristopherChief Financial OfficerS — Open-market sale19.3K$6.42$124KSEC
Chu Yu-WayeChief Medical OfficerS — Open-market sale21.3K$6.42$137KSEC
McCarthy Sean A.CEOS — Open-market sale119.0K$6.42$764KSEC
BELVIN MARCIASVP, Chief Scientific OfficerS — Open-market sale31.5K$6.42$202KSEC
Lester RachaelChief Business OfficerA — Grant or award20.0K$0.00SEC
Chu Yu-WayeChief Medical OfficerA — Grant or award75.0K$0.00SEC
BELVIN MARCIASVP, Chief Scientific OfficerA — Grant or award60.0K$0.00SEC
Ogden ChristopherChief Financial OfficerA — Grant or award90.0K$0.00SEC
McCarthy Sean A.CEOA — Grant or award210.0K$0.00SEC

All transactions sourced from SEC EDGAR Form 4 filings for CytomX Therapeutics, Inc. (CTMX). Updated in real time as new filings are submitted to the SEC.

Most-Active CTMX Insiders — Last 90 Days

InsiderForm 4 filingsTotal transaction value
Ogden Christopher1$5K
Meyers James R1
Mohindru Mani1
Jones Elaine V1
Gilbert Halley E1

Recent CTMX Form 8-K Material Events

Recent Insider Filings

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in CTMX insider filings:

POpen-market purchase by the insider
SOpen-market sale by the insider
AGrant, award, or other acquisition from the issuer
MExercise or conversion of derivative security (e.g. options)
FPayment of exercise price or tax liability via share withholding
GBona-fide gift of securities
DDisposition to the issuer (e.g. share buyback participation)
JOther acquisition or disposition
XExercise of in-the-money or at-the-money derivative security
CConversion of derivative security
VTransaction voluntarily reported earlier than required

CTMX Insider Trading — FAQ

What is the latest insider trade for CTMX?
CytomX Therapeutics, Inc. (CTMX) had 8 insider filings in the last 90 days, with the most recent on 2026-06-22. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying CTMX stock?
0 insider purchases of CTMX were filed in the last 90 days.
How many insiders are selling CTMX stock?
0 insider sales of CTMX were filed in the last 90 days.
Where can I see CTMX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
InsiderAlpha aggregates every CTMX SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live CTMX dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.